Showing results (41-50 of 60) with videos related to
Sort By:
Pageof 6
The Journal of Biological Chemistry|July 27, 2001
Fibroblast growth factor-2 antagonist activity and angiostatic capacity of sulfated Escherichia coli K5 polysaccharide derivativesD Leali, M Belleri, C Urbinati, et al.Endothelium : Journal of Endothelial Cell Research|June 21, 2001
Activation of endothelial cell mitogen activated protein kinase ERK(1/2) by extracellular HIV-1 Tat proteinM Rusnati, C Urbinati, B Musulin, et al.Oncogene|January 18, 1996
HIV-tat protein is a heparin-binding angiogenic growth factorA Albini, R Benelli, M Presta, et al.The Journal of Biological Chemistry|June 20, 1998
The basic domain in HIV-1 Tat protein as a target for polysulfonated heparin-mimicking extracellular Tat antagonistsM Rusnati, G Tulipano, C Urbinati, et al.AIDS (London, England)|May 1, 1997
Upregulation of urokinase-type plasminogen activator by endogenous and exogenous HIV-1 Tat protein in tumour cell lines derived from BK virus/tat-transgenic miceM Rusnati, D Coltrini, D Campioni, et al.Cancer Letters|September 1, 1987
Critical role of gonadal hormones on the genotoxic activity of the hepatocarcinogen DL-ZAMI 1305G Ragnotti, M Presta, J A Maier, et al.Current Pharmaceutical Design|February 7, 2003
Heparin derivatives as angiogenesis inhibitorsM Presta, D Leali, H Stabile, et al.The Journal of Biological Chemistry|April 25, 1997
Interaction of HIV-1 Tat protein with heparin. Role of the backbone structure, sulfation, and sizeM Rusnati, D Coltrini, P Oreste, et al.The Journal of Pathology|January 12, 2000
Alterations of blood vessel development by endothelial cells overexpressing fibroblast growth factor-2D Ribatti, A Gualandris, M Belleri, et al.Molecular Pharmacology|July 1, 1999
Modulation of fibroblast growth factor-2 receptor binding, signaling, and mitogenic activity by heparin-mimicking polysulfonated compoundsS Liekens, D Leali, J Neyts, et al.Pageof 6